References
- Polprasert C, Schulze I, Sekeres MA, et al. Inherited and somatic defects in DDX41 in myeloid neoplasms. Cancer Cell. 2015;27:658–670.
- Jerez A, Gondek LP, Jankowska AM, et al. Topography, clinical, and genomic correlates of 5q myeloid malignancies revisited. Jco. 2012;30:1343–1349.
- Berger G, van den Berg E, Sikkema-Raddatz B, et al. Re-emergence of acute myeloid leukemia in donor cells following allogeneic transplantation in a family with a germline DDX41 mutation. Leukemia. 2017;31:520–522.
- Jagadeesh KA, Wenger AM, Berger MJ, et al. M-CAP eliminates a majority of variants of uncertain significance in clinical exomes at high sensitivity. Nat Genet. 2016;48:1581–1586.
- Bendl J, Musil M, Stourac J, et al. PredictSNP2: a unified platform for accurately evaluating SNP effects by exploiting the different characteristics of variants in distinct genomicr. PLoS Comput Biol. 2016;12:e1004962.
- Gussow AB, Petrovski S, Wang Q, et al. The intolerance to functional genetic variation of protein domains predicts the localization of pathogenic mutations within genes. Genome Biol. 2016;17:9.
- Goldin LR, Kristinsson SY, Liang XS, et al. Familial aggregation of acute myeloid leukemia and myelodysplastic syndromes. Jco. 2012;30:179–183.
- International Agency for Research on Cancer, World Health Organization. WHO classification of tumours of haematopoietic and lymphoid tissues. Northwestern University: International Agency for Research on Cancer; 2008.
- Sperling AS, Gibson CJ, Ebert BL. The genetics of myelodysplastic syndrome: from clonal haematopoiesis to secondary leukaemia. Nat Rev Cancer. 2017;17:5–19.
- Kennedy JA, Ebert BL. Clinical implications of genetic mutations in myelodysplastic syndrome. Jco. 2017;35:968–974.
- Jiang Y, Zhu Y, Qiu W, et al. Structural and functional analyses of human DDX41 DEAD domain. Protein Cell. 2017;8:72–76.
- Cheah JJC, Hahn CN, Hiwase DK, et al. Myeloid neoplasms with germline DDX41 mutation. Int J Hematol. 2017;106:163–174.
- Lewinsohn M, Brown AL, Weinel LM, et al. Novel germ line DDX41 mutations define families with a lower age of MDS/AML onset and lymphoid malignancies. Blood. 2016;127:1017–1023.
- Li R, Sobreira N, Witmer PD, et al. Two novel germline DDX41 mutations in a family with inherited myelodysplasia/acute myeloid leukemia. Haematologica. 2016;101:e228–e231.